Orthofix Medical opened higher at $7.20, compared with its previous close of $7.18. In the last trading session, the stock traded between $6.91 and $7.39. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Orthofix Medical is now worth
$ 21.29
Resulting in a loss of
$ 78.71 (78.71%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
66.67%
Hold
33.33%
Sell
0%
Markets Today
Today's Change
$-0.23 (-3.23%)
Day High
$7.39
Day Low
$6.91
Day Open
$7.20
Prev Close
$7.18
Volume
4,56,135
1W Return
-28.41%
1M Return
-25.17%
3M Return
-32.63%
6M Return
-40.46%
1Y Return
-54.82%
Fundamentals
Market Cap ($ Mn)
283
PE Ratio
-
PB Ratio
0.92
PEG Ratio
-
ROE
-19.94%
ROCE
-10.64%
EPS (TTM)
$-0.15
Investment Returns
1 Week
-28.41%
1 Month
-25.17%
3 Months
-32.63%
6 Months
-40.46%
9 Months
-48.53%
Financials
Quarterly
All values in $ Mn
203.1
Jun 25
205.6
Sep 25
219.9
Dec 25
196.7
Mar 26
210.9
Jun 26
207.9
Sep 26
Updates
14Oct
Halper Sadeh probes Orthofix Medical for potential fiduciary breaches
Halper Sadeh LLC investigates Orthofix Medical Inc. for fiduciary duty breaches. Long-term shareholders urged to seek governance reforms and fund returns. Legal representation offered on a contingent fee basis with no upfront costs.
1mo ago
20Jul
Orthofix Medical Inc to attend August investor conferences
Orthofix Medical Inc announced it will participate in the Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026. The fireside chat at the Boston conference will be available via webcast on the company's investor relations website.
3mo ago
7Jul
Medicare restores pre-May 18 rates for bone growth stimulators
CMS reversed its May 18 billing changes for bone growth stimulators, restoring pre-reclassification reimbursement rates for Orthofix Medical Inc. The FDA's April 16 order reclassifying the devices had initially prompted the Medicare fee schedule adjustments.
4mo ago
18Jun
Alpha buying screen identifies four stocks near lows with insider support
A recent investment screen identified four companies trading near three-year lows with significant insider buying, aiming to replicate a deep-value strategy. The candidates include Orthofix Medical, American Integrity Insurance Group, Crescent Capital BDC, and Swiss Helvetia Fund, all selected for their low valuations and management confidence.
